| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 7.42e-05 | 17 | 98 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 1.23e-04 | 20 | 98 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 4.53e-04 | 130 | 98 | 5 | GO:0005200 | |
| GeneOntologyMolecularFunction | interleukin-17 receptor activity | 6.55e-04 | 8 | 98 | 2 | GO:0030368 | |
| GeneOntologyMolecularFunction | alpha-(1->3)-fucosyltransferase activity | 6.55e-04 | 8 | 98 | 2 | GO:0046920 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 7.28e-04 | 36 | 98 | 3 | GO:0070273 | |
| GeneOntologyBiologicalProcess | DNA replication, Okazaki fragment processing | 2.19e-05 | 2 | 97 | 2 | GO:0033567 | |
| GeneOntologyCellularComponent | intercellular bridge | 5.31e-06 | 94 | 98 | 6 | GO:0045171 | |
| GeneOntologyCellularComponent | tubulin complex | 6.51e-05 | 3 | 98 | 2 | GO:0045298 | |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 7.75e-05 | 18 | 98 | 3 | GO:0000159 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 3.22e-04 | 6 | 98 | 2 | GO:0033165 | |
| Domain | Beta-tubulin_BS | 8.41e-10 | 10 | 97 | 5 | IPR013838 | |
| Domain | Beta_tubulin | 8.41e-10 | 10 | 97 | 5 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 1.53e-09 | 11 | 97 | 5 | PS00228 | |
| Domain | - | 4.96e-08 | 20 | 97 | 5 | 3.30.1330.20 | |
| Domain | - | 6.49e-08 | 21 | 97 | 5 | 1.10.287.600 | |
| Domain | Tubulin_C | 8.36e-08 | 22 | 97 | 5 | SM00865 | |
| Domain | Tubulin_C | 8.36e-08 | 22 | 97 | 5 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 8.36e-08 | 22 | 97 | 5 | IPR018316 | |
| Domain | - | 8.36e-08 | 22 | 97 | 5 | 3.40.50.1440 | |
| Domain | Tubulin_C | 1.06e-07 | 23 | 97 | 5 | IPR023123 | |
| Domain | TUBULIN | 1.06e-07 | 23 | 97 | 5 | PS00227 | |
| Domain | Tubulin | 1.06e-07 | 23 | 97 | 5 | IPR000217 | |
| Domain | Tub_FtsZ_C | 1.06e-07 | 23 | 97 | 5 | IPR008280 | |
| Domain | Tubulin | 1.06e-07 | 23 | 97 | 5 | SM00864 | |
| Domain | Tubulin_CS | 1.06e-07 | 23 | 97 | 5 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 1.34e-07 | 24 | 97 | 5 | IPR003008 | |
| Domain | Tubulin | 1.34e-07 | 24 | 97 | 5 | PF00091 | |
| Domain | PP2A_B56 | 1.35e-06 | 5 | 97 | 3 | IPR002554 | |
| Domain | B56 | 1.35e-06 | 5 | 97 | 3 | PF01603 | |
| Domain | fn3 | 2.17e-05 | 162 | 97 | 7 | PF00041 | |
| Domain | FN3 | 5.06e-05 | 185 | 97 | 7 | SM00060 | |
| Domain | FN3 | 8.02e-05 | 199 | 97 | 7 | PS50853 | |
| Domain | FN3_dom | 1.09e-04 | 209 | 97 | 7 | IPR003961 | |
| Domain | EGF_Ca-bd_CS | 1.50e-04 | 97 | 97 | 5 | IPR018097 | |
| Domain | EGF_CA | 1.66e-04 | 99 | 97 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.74e-04 | 100 | 97 | 5 | PS00010 | |
| Domain | EGF_3 | 2.24e-04 | 235 | 97 | 7 | PS50026 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.28e-04 | 106 | 97 | 5 | IPR000152 | |
| Domain | EGF-like_dom | 3.19e-04 | 249 | 97 | 7 | IPR000742 | |
| Domain | EGF_1 | 3.68e-04 | 255 | 97 | 7 | PS00022 | |
| Domain | - | 3.95e-04 | 6 | 97 | 2 | 2.40.50.90 | |
| Domain | Staphylococal_nuclease_OB-fold | 3.95e-04 | 6 | 97 | 2 | IPR016071 | |
| Domain | EGF-like_CS | 4.23e-04 | 261 | 97 | 7 | IPR013032 | |
| Domain | EGF_CA | 4.37e-04 | 122 | 97 | 5 | SM00179 | |
| Domain | EGF_2 | 4.64e-04 | 265 | 97 | 7 | PS01186 | |
| Domain | EGF-like_Ca-bd_dom | 4.71e-04 | 124 | 97 | 5 | IPR001881 | |
| Domain | Glyco_transf_10 | 7.32e-04 | 8 | 97 | 2 | PF00852 | |
| Domain | Glyco_tran_10_N | 7.32e-04 | 8 | 97 | 2 | PF17039 | |
| Domain | Glyco_trans_10 | 7.32e-04 | 8 | 97 | 2 | IPR001503 | |
| Domain | Glyco_tran_10_N | 7.32e-04 | 8 | 97 | 2 | IPR031481 | |
| Domain | EGF | 1.42e-03 | 235 | 97 | 6 | SM00181 | |
| Domain | WD40_repeat_CS | 1.65e-03 | 164 | 97 | 5 | IPR019775 | |
| Domain | WW | 1.87e-03 | 47 | 97 | 3 | PF00397 | |
| Domain | WW | 1.98e-03 | 48 | 97 | 3 | SM00456 | |
| Domain | LINK | 2.01e-03 | 13 | 97 | 2 | SM00445 | |
| Domain | Link_dom | 2.01e-03 | 13 | 97 | 2 | IPR000538 | |
| Domain | Xlink | 2.01e-03 | 13 | 97 | 2 | PF00193 | |
| Domain | LINK_1 | 2.01e-03 | 13 | 97 | 2 | PS01241 | |
| Domain | LINK_2 | 2.01e-03 | 13 | 97 | 2 | PS50963 | |
| Domain | TUDOR | 2.33e-03 | 14 | 97 | 2 | PF00567 | |
| Domain | WW_DOMAIN_2 | 2.36e-03 | 51 | 97 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 2.36e-03 | 51 | 97 | 3 | PS01159 | |
| Domain | WW_dom | 2.50e-03 | 52 | 97 | 3 | IPR001202 | |
| Domain | WD40 | 2.74e-03 | 268 | 97 | 6 | SM00320 | |
| Domain | Leu-rich_rpt | 2.90e-03 | 271 | 97 | 6 | IPR001611 | |
| Domain | WD40_repeat | 2.95e-03 | 272 | 97 | 6 | IPR001680 | |
| Domain | WD_REPEATS_1 | 3.29e-03 | 278 | 97 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.35e-03 | 279 | 97 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.35e-03 | 279 | 97 | 6 | PS50294 | |
| Domain | EGF | 4.22e-03 | 126 | 97 | 4 | PF00008 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 4.31e-03 | 19 | 97 | 2 | IPR006553 | |
| Domain | LRR_CC | 4.31e-03 | 19 | 97 | 2 | SM00367 | |
| Domain | WD40_repeat_dom | 4.53e-03 | 297 | 97 | 6 | IPR017986 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.56e-09 | 25 | 73 | 6 | M47775 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.91e-08 | 17 | 73 | 5 | M47768 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.25e-08 | 35 | 73 | 6 | M47774 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.63e-08 | 18 | 73 | 5 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.56e-08 | 19 | 73 | 5 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.56e-08 | 19 | 73 | 5 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 4.73e-08 | 20 | 73 | 5 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 4.73e-08 | 20 | 73 | 5 | M47911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 6.18e-08 | 21 | 73 | 5 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 7.97e-08 | 22 | 73 | 5 | M47903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.01e-07 | 23 | 73 | 5 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.01e-07 | 23 | 73 | 5 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.28e-07 | 24 | 73 | 5 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.28e-07 | 24 | 73 | 5 | M47700 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.59e-07 | 25 | 73 | 5 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.96e-07 | 26 | 73 | 5 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 2.90e-07 | 28 | 73 | 5 | M47898 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 6.87e-07 | 33 | 73 | 5 | M47901 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.50e-06 | 17 | 73 | 4 | MM14731 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 2.68e-06 | 43 | 73 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 2.68e-06 | 43 | 73 | 5 | M47773 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 3.37e-06 | 45 | 73 | 5 | M47670 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.71e-06 | 21 | 73 | 4 | M27067 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.06e-06 | 127 | 73 | 7 | M27181 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.50e-06 | 129 | 73 | 7 | MM14894 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 5.44e-06 | 23 | 73 | 4 | M19135 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 6.21e-06 | 191 | 73 | 8 | M29614 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 6.71e-06 | 193 | 73 | 8 | MM14890 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 7.73e-06 | 140 | 73 | 7 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 8.10e-06 | 141 | 73 | 7 | MM15266 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 9.08e-06 | 26 | 73 | 4 | M9648 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 9.22e-06 | 55 | 73 | 5 | M39613 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 9.37e-06 | 202 | 73 | 8 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.01e-05 | 204 | 73 | 8 | M4217 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.01e-05 | 56 | 73 | 5 | M2333 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.06e-05 | 27 | 73 | 4 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.06e-05 | 27 | 73 | 4 | MM15674 | |
| Pathway | REACTOME_CELL_CYCLE | UIMC1 POLD1 TUBB TUBB2B TUBB2A LIG1 TUBB4A TUBB4B PPP2R5A PPP2R5D PPP2R5E ANAPC1 SYNE2 DNA2 | 1.07e-05 | 694 | 73 | 14 | M543 |
| Pathway | REACTOME_CELL_CYCLE | UIMC1 POLD1 TUBB TUBB2B TUBB2A LIG1 TUBB4A TUBB4B PPP2R5A PPP2R5D PPP2R5E ANAPC1 DNA2 | 1.14e-05 | 603 | 73 | 13 | MM14635 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.43e-05 | 29 | 73 | 4 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.43e-05 | 29 | 73 | 4 | M27948 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | NEDD4L FBXL15 RNF213 TUBB2B TUBB2A FBXL5 TUBB4A TUBB4B PPP2R5A PPP2R5D PPP2R5E PTPRJ ANAPC1 UBAC1 | 1.59e-05 | 719 | 73 | 14 | MM14540 |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.13e-05 | 32 | 73 | 4 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.13e-05 | 32 | 73 | 4 | M27491 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.13e-05 | 32 | 73 | 4 | MM14730 | |
| Pathway | KEGG_MEDICUS_REFERENCE_OKAZAKI_FRAGMENT_MATURATION | 2.13e-05 | 11 | 73 | 3 | M47860 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.27e-05 | 66 | 73 | 5 | MM17074 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.42e-05 | 33 | 73 | 4 | M27297 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.72e-05 | 234 | 73 | 8 | MM14898 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | POLD1 TUBB TUBB2B TUBB2A LIG1 TUBB4A TUBB4B PPP2R5A PPP2R5D PPP2R5E ANAPC1 DNA2 | 2.80e-05 | 561 | 73 | 12 | M5336 |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.89e-05 | 236 | 73 | 8 | M27185 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 3.23e-05 | 71 | 73 | 5 | M39690 | |
| Pathway | REACTOME_AGGREPHAGY | 3.44e-05 | 36 | 73 | 4 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.84e-05 | 37 | 73 | 4 | MM15102 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 4.28e-05 | 38 | 73 | 4 | M14981 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 4.50e-05 | 76 | 73 | 5 | M48037 | |
| Pathway | REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS | 5.80e-05 | 15 | 73 | 3 | M27407 | |
| Pathway | REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND | 5.80e-05 | 15 | 73 | 3 | MM15373 | |
| Pathway | REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND | 5.80e-05 | 15 | 73 | 3 | M744 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE | 7.11e-05 | 16 | 73 | 3 | M47870 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | NEDD4L FBXL15 RNF213 TUBB2B TUBB2A FBXL5 TUBB4A TUBB4B PPP2R5A PPP2R5D PPP2R5E PTPRJ ANAPC1 UBAC1 | 7.51e-05 | 828 | 73 | 14 | M1058 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 7.68e-05 | 44 | 73 | 4 | MM14606 | |
| Pathway | REACTOME_AGGREPHAGY | 7.68e-05 | 44 | 73 | 4 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 7.68e-05 | 44 | 73 | 4 | M27934 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 8.60e-05 | 17 | 73 | 3 | MM15096 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 8.60e-05 | 17 | 73 | 3 | M27083 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 8.60e-05 | 17 | 73 | 3 | M919 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 9.16e-05 | 46 | 73 | 4 | M27828 | |
| Pathway | KEGG_GAP_JUNCTION | 1.01e-04 | 90 | 73 | 5 | M4013 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.01e-04 | 90 | 73 | 5 | MM14979 | |
| Pathway | REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE | 1.03e-04 | 18 | 73 | 3 | MM14682 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 1.03e-04 | 18 | 73 | 3 | MM14759 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.08e-04 | 48 | 73 | 4 | MM15353 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | KALRN MYO19 OBSCN TUBB2B TUBB2A TUBB4A TUBB4B PPP2R5A PPP2R5D PPP2R5E NISCH SCRIB | 1.14e-04 | 649 | 73 | 12 | MM15690 |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.18e-04 | 49 | 73 | 4 | M891 | |
| Pathway | REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE | 1.22e-04 | 19 | 73 | 3 | M27029 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 1.22e-04 | 19 | 73 | 3 | M47525 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.24e-04 | 94 | 73 | 5 | MM14515 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.31e-04 | 95 | 73 | 5 | M6729 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.38e-04 | 51 | 73 | 4 | M26972 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING | 1.43e-04 | 20 | 73 | 3 | M47876 | |
| Pathway | REACTOME_LAGGING_STRAND_SYNTHESIS | 1.43e-04 | 20 | 73 | 3 | M9461 | |
| Pathway | REACTOME_LAGGING_STRAND_SYNTHESIS | 1.43e-04 | 20 | 73 | 3 | MM15374 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.48e-04 | 52 | 73 | 4 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.48e-04 | 52 | 73 | 4 | MM15211 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | IL11RA TUBB2B TUBB2A TUBB4A TUBB4B PPP2R5A PPP2R5D PTPRJ GSDMD IL27RA | 1.51e-04 | 472 | 73 | 10 | MM14539 |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.51e-04 | 98 | 73 | 5 | M776 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.54e-04 | 156 | 73 | 6 | M27097 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.60e-04 | 53 | 73 | 4 | M27651 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 1.66e-04 | 21 | 73 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 1.66e-04 | 21 | 73 | 3 | MM14996 | |
| Pathway | REACTOME_M_PHASE | TUBB TUBB2B TUBB2A TUBB4A TUBB4B PPP2R5A PPP2R5D PPP2R5E ANAPC1 | 1.66e-04 | 387 | 73 | 9 | MM15364 |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.72e-04 | 54 | 73 | 4 | M27482 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 1.91e-04 | 22 | 73 | 3 | M47919 | |
| Pathway | REACTOME_KINESINS | 2.12e-04 | 57 | 73 | 4 | MM15714 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.12e-04 | 57 | 73 | 4 | M27251 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 2.31e-04 | 168 | 73 | 6 | MM14785 | |
| Pathway | REACTOME_DNA_STRAND_ELONGATION | 2.49e-04 | 24 | 73 | 3 | MM15375 | |
| Pathway | REACTOME_KINESINS | 2.76e-04 | 61 | 73 | 4 | M977 | |
| Pathway | REACTOME_M_PHASE | TUBB TUBB2B TUBB2A TUBB4A TUBB4B PPP2R5A PPP2R5D PPP2R5E ANAPC1 | 2.89e-04 | 417 | 73 | 9 | M27662 |
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 9.88e-12 | 8 | 100 | 5 | 23246003 | |
| Pubmed | 2.54e-11 | 21 | 100 | 6 | 30110642 | ||
| Pubmed | 6.43e-11 | 4 | 100 | 4 | 11120798 | ||
| Pubmed | Mitochondria-cytoskeleton interaction: distribution of β-tubulins in cardiomyocytes and HL-1 cells. | 3.21e-10 | 5 | 100 | 4 | 21296049 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KALRN OBSCN APBB3 AKNA LMTK2 APEH BTAF1 EDC4 ZZEF1 ANO8 SCAP PLEKHM2 PIK3C2B NISCH PKD1 SEC16A ANKRD11 TEX19 PRRC2B | 3.45e-10 | 1105 | 100 | 19 | 35748872 |
| Pubmed | RELN GAMT KALRN TUBB APBB3 APEH CHD9 TUBB2B HNRNPUL1 PRPF8 LRP1B TUBB2A TUBB4A TUBB4B NAA25 PPP2R5E NISCH PKD1 SCRIB ABHD12 | 6.25e-10 | 1285 | 100 | 20 | 35914814 | |
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 3782288 | ||
| Pubmed | 9.61e-10 | 6 | 100 | 4 | 24275654 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 4.50e-09 | 22 | 100 | 5 | 16526095 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 4.50e-09 | 22 | 100 | 5 | 23826228 | |
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 4.50e-09 | 22 | 100 | 5 | 30446499 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 6688039 | ||
| Pubmed | TUBB APEH MUC16 RNF213 HNRNPUL1 TUBB2A LIG1 TUBB4B PLEKHM2 SEC16A CD44 SCRIB CTNND1 PRRC2B | 5.15e-08 | 777 | 100 | 14 | 35844135 | |
| Pubmed | 7.33e-08 | 187 | 100 | 8 | 26460568 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 19545277 | ||
| Pubmed | POLD1 FAT3 RNF213 CHD9 ZZEF1 ZNF829 PPP2R5A SOWAHA PPP2R5E HMCN2 SAT1 ANAPC1 SEC16A SCRIB DNA2 PRRC2B | 1.22e-07 | 1116 | 100 | 16 | 31753913 | |
| Pubmed | NEDD4L KALRN RBP3 TUBB TUBB2B EDC4 TUBB2A TUBB4A TUBB4B NWD2 PPP2R5E NISCH VCAN SEC16A SCRIB CTNND1 ABHD12 PRRC2B | 1.28e-07 | 1431 | 100 | 18 | 37142655 | |
| Pubmed | 1.49e-07 | 17 | 100 | 4 | 17360745 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | NEDD4L TUBB APEH EDC4 PRPF8 TUBB2A VCAN SYNE2 SEC16A SCRIB ABHD12 | 2.09e-07 | 498 | 100 | 11 | 36634849 |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 8812429 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 15095873 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 7472403 | ||
| Pubmed | Five mouse tubulin isotypes and their regulated expression during development. | 2.30e-07 | 5 | 100 | 3 | 3839797 | |
| Pubmed | 2.41e-07 | 19 | 100 | 4 | 15698476 | ||
| Pubmed | 2.41e-07 | 19 | 100 | 4 | 15691386 | ||
| Pubmed | 2.52e-07 | 148 | 100 | 7 | 35676246 | ||
| Pubmed | TUBB TUBB2B HNRNPUL1 PRPF8 TUBB2A TUBB4A TUBB4B SMPDL3B SEC16A CTNND1 | 3.99e-07 | 421 | 100 | 10 | 34650049 | |
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 5.02e-07 | 54 | 100 | 5 | 21525035 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 5.24e-07 | 332 | 100 | 9 | 32786267 | |
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 8703017 | ||
| Pubmed | Identification of a new family of protein phosphatase 2A regulatory subunits. | 8.01e-07 | 7 | 100 | 3 | 7592815 | |
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 27010057 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | LMTK2 TUBB2B PRPF8 TUBB2A TUBB4A TUBB4B PPP2R5A PPP2R5D GANAB PPP2R5E SEC16A | 8.32e-07 | 573 | 100 | 11 | 28330616 |
| Pubmed | Tex19 paralogs are new members of the piRNA pathway controlling retrotransposon suppression. | 1.28e-06 | 8 | 100 | 3 | 28254886 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NEDD4L TUBB2B BTAF1 HNRNPUL1 EDC4 PRPF8 F5 TUBB4B GANAB SMPDL3B SYNE2 SEC16A SCRIB CTNND1 | 1.42e-06 | 1024 | 100 | 14 | 24711643 |
| Pubmed | 1.66e-06 | 30 | 100 | 4 | 25864199 | ||
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 1.73e-06 | 125 | 100 | 6 | 36030824 | |
| Pubmed | 1.78e-06 | 198 | 100 | 7 | 24337577 | ||
| Pubmed | LMTK2 RNF213 TUBB2A PPP2R5A PPP2R5D GANAB PPP2R5E PTPRJ SYNE2 SEC16A CD44 SCRIB CTNND1 PRRC2B | 1.88e-06 | 1049 | 100 | 14 | 27880917 | |
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 30595372 | ||
| Pubmed | Direct binding between BubR1 and B56-PP2A phosphatase complexes regulate mitotic progression. | 1.91e-06 | 9 | 100 | 3 | 23345399 | |
| Pubmed | Postnatal refinement of auditory hair cell planar polarity deficits occurs in the absence of Vangl2. | 2.73e-06 | 10 | 100 | 3 | 23986237 | |
| Pubmed | ASXL1 NEDD4L GANAB PPP2R5E PLEKHM2 NISCH SEC16A SCRIB PRRC2B | 2.80e-06 | 407 | 100 | 9 | 12693553 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | POLD1 TUBB TUBB2B BTAF1 HNRNPUL1 PRPF8 TUBB2A TUBB4A TUBB4B GANAB ANAPC1 SEC16A SCRIB CTNND1 DNA2 | 3.08e-06 | 1257 | 100 | 15 | 37317656 |
| Pubmed | POLD1 MYO19 RNF213 TUBB2B BTAF1 HNRNPUL1 EDC4 PRPF8 TUBB2A MRPS10 TUBB4A GANAB SYNE2 CD44 SCRIB PRRC2B | 3.47e-06 | 1440 | 100 | 16 | 30833792 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 3.48e-06 | 219 | 100 | 7 | 31353912 | |
| Pubmed | TUBB CHD9 TUBB2B HNRNPUL1 EDC4 PRPF8 TUBB2A TUBB4A TUBB4B PPP2R5D GANAB ANAPC1 | 3.74e-06 | 809 | 100 | 12 | 32129710 | |
| Pubmed | 3.74e-06 | 11 | 100 | 3 | 32140098 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | VASN POLD1 TUBB APEH HNRNPUL1 EDC4 ZZEF1 TUBB2A LIG1 TUBB4A TUBB4B PPP2R5D GANAB PPP2R5E SEC16A CD44 | 3.96e-06 | 1455 | 100 | 16 | 22863883 |
| Pubmed | MAGI1 NEDD4L KALRN TUBB2B EDC4 PPP2R5D ANAPC1 NISCH SYNE2 SEC16A SCRIB CTNND1 PRRC2B | 4.00e-06 | 963 | 100 | 13 | 28671696 | |
| Pubmed | 4.98e-06 | 12 | 100 | 3 | 15380617 | ||
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 4.98e-06 | 12 | 100 | 3 | 15331610 | |
| Pubmed | Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I. | 4.98e-06 | 12 | 100 | 3 | 16541024 | |
| Pubmed | POLD1 TUBB APEH HNRNPUL1 PRPF8 MRPS10 TUBB4A PPP2R5D GANAB NISCH SYNE2 ANKRD11 SCRIB CTNND1 DNA2 ABHD12 | 5.21e-06 | 1487 | 100 | 16 | 33957083 | |
| Pubmed | 5.43e-06 | 40 | 100 | 4 | 30865227 | ||
| Pubmed | 5.50e-06 | 332 | 100 | 8 | 37433992 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 5.52e-06 | 235 | 100 | 7 | 30258100 | |
| Pubmed | TUBB MUC16 RNF213 TUBB2B HNRNPUL1 PRPF8 TUBB2A TUBB4A TUBB4B GANAB SEC16A CTNND1 | 5.74e-06 | 844 | 100 | 12 | 25963833 | |
| Pubmed | 6.23e-06 | 156 | 100 | 6 | 32850835 | ||
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 6.46e-06 | 13 | 100 | 3 | 10908577 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 21072166 | ||
| Pubmed | 6.62e-06 | 42 | 100 | 4 | 29107558 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAGI1 NEDD4L LMTK2 HNRNPUL1 EDC4 MYLK3 PIK3C2B SYNE2 SEC16A ANKRD11 SCRIB CTNND1 | 7.02e-06 | 861 | 100 | 12 | 36931259 |
| Pubmed | 7.06e-06 | 244 | 100 | 7 | 30349055 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | POLD1 TUBB BTAF1 EDC4 PRPF8 RNF17 TUBB4B ANAPC1 SCRIB CTNND1 | 7.16e-06 | 582 | 100 | 10 | 20467437 |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30621030 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 8270253 | ||
| Pubmed | Evaluating stem and cancerous biomarkers in CD15+CD44+ KYSE30 cells. | 8.18e-06 | 2 | 100 | 2 | 23797812 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35069585 | ||
| Pubmed | Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer. | 8.18e-06 | 2 | 100 | 2 | 38696842 | |
| Pubmed | CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma. | 8.18e-06 | 2 | 100 | 2 | 17957481 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17627938 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 15951026 | ||
| Pubmed | Versican and CD44 in in vitro valvular interstitial cell injury and repair. | 8.18e-06 | 2 | 100 | 2 | 21546273 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 38031972 | ||
| Pubmed | Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behavior. | 8.18e-06 | 2 | 100 | 2 | 21136024 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 6865944 | ||
| Pubmed | 8.20e-06 | 14 | 100 | 3 | 12486001 | ||
| Pubmed | 8.20e-06 | 14 | 100 | 3 | 9400615 | ||
| Pubmed | 8.20e-06 | 14 | 100 | 3 | 16048649 | ||
| Pubmed | Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr. | 8.20e-06 | 14 | 100 | 3 | 9013886 | |
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 8.39e-06 | 95 | 100 | 5 | 27129302 | |
| Pubmed | 1.03e-05 | 99 | 100 | 5 | 29676259 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CRISPLD2 NEDD4L VASN TUBB APEH GALNT7 TUBB4A TUBB4B GANAB SMPDL3B PTPRJ BHMT2 CD44 | 1.23e-05 | 1070 | 100 | 13 | 23533145 |
| Pubmed | 1.24e-05 | 266 | 100 | 7 | 19380743 | ||
| Pubmed | 1.26e-05 | 16 | 100 | 3 | 14594945 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NEDD4L POLD1 TUBB TUBB2B HNRNPUL1 PRPF8 TUBB2A MRPS10 TUBB4B PPP2R5D GANAB SYNE2 SEC16A MPLKIP CTNND1 | 1.27e-05 | 1415 | 100 | 15 | 28515276 |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 1.30e-05 | 104 | 100 | 5 | 36055981 | |
| Pubmed | Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. | 1.34e-05 | 50 | 100 | 4 | 24769233 | |
| Pubmed | 1.34e-05 | 50 | 100 | 4 | 23703321 | ||
| Pubmed | 1.45e-05 | 51 | 100 | 4 | 36896912 | ||
| Pubmed | 1.52e-05 | 17 | 100 | 3 | 17266553 | ||
| Pubmed | [Action of protein phosphatase-1 on Tat-dependent HIV-1 transcription and its related inhibitors]. | 1.52e-05 | 17 | 100 | 3 | 21351466 | |
| Pubmed | 1.55e-05 | 183 | 100 | 6 | 23956138 | ||
| Pubmed | 1.60e-05 | 277 | 100 | 7 | 30745168 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | TUBB TUBB2B PRPF8 TUBB2A TUBB4A TUBB4B PPP2R5D PPP2R5E SEC16A CTNND1 | 1.60e-05 | 639 | 100 | 10 | 23443559 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | BTAF1 EDC4 GALNT7 TUBB2A NAA25 PPP2R5D SCAP GANAB PPP2R5E NISCH SCRIB ABHD12 | 1.72e-05 | 942 | 100 | 12 | 31073040 |
| Pubmed | 1.82e-05 | 18 | 100 | 3 | 23287597 | ||
| Pubmed | 1.97e-05 | 396 | 100 | 8 | 26687479 | ||
| Pubmed | 2.16e-05 | 19 | 100 | 3 | 21572392 | ||
| Interaction | TPSB2 interactions | 1.90e-08 | 18 | 97 | 5 | int:TPSB2 | |
| Interaction | CAPS interactions | 1.15e-07 | 25 | 97 | 5 | int:CAPS | |
| Interaction | ZC2HC1B interactions | 2.10e-07 | 28 | 97 | 5 | int:ZC2HC1B | |
| Interaction | BAGE2 interactions | 1.09e-06 | 70 | 97 | 6 | int:BAGE2 | |
| Interaction | RSPH1 interactions | 3.30e-06 | 131 | 97 | 7 | int:RSPH1 | |
| Interaction | CDC42SE2 interactions | 3.45e-06 | 22 | 97 | 4 | int:CDC42SE2 | |
| Interaction | ARL2 interactions | 3.47e-06 | 132 | 97 | 7 | int:ARL2 | |
| Interaction | PPEF1 interactions | 5.06e-06 | 52 | 97 | 5 | int:PPEF1 | |
| Interaction | TOP3B interactions | KALRN OBSCN APBB3 AKNA LMTK2 APEH BTAF1 EDC4 ZZEF1 ANO8 SCAP PLEKHM2 PIK3C2B NISCH PKD1 SEC16A ANKRD11 DNA2 TEX19 PRRC2B | 1.91e-05 | 1470 | 97 | 20 | int:TOP3B |
| Interaction | SUMO2 interactions | UIMC1 KALRN POLD1 TUBB RNF213 EDC4 PRPF8 TUBB4A TUBB4B ANAPC1 CTNND1 SENP5 | 2.66e-05 | 591 | 97 | 12 | int:SUMO2 |
| Interaction | GAN interactions | 3.05e-05 | 253 | 97 | 8 | int:GAN | |
| Interaction | TCP11L1 interactions | 3.08e-05 | 75 | 97 | 5 | int:TCP11L1 | |
| Interaction | RNF43 interactions | TUBB OBSCN TUBB2B TUBB2A TUBB4A TUBB4B SEC16A SCRIB CTNND1 PRRC2B | 3.99e-05 | 427 | 97 | 10 | int:RNF43 |
| Interaction | OSTM1 interactions | 4.21e-05 | 80 | 97 | 5 | int:OSTM1 | |
| Interaction | WBP2 interactions | 4.74e-05 | 82 | 97 | 5 | int:WBP2 | |
| Interaction | UBC interactions | UIMC1 TUBB LMTK2 RNF213 TUBB2A TUBB4A TUBB4B PIK3C2B UBAC1 CTNND1 | 5.75e-05 | 446 | 97 | 10 | int:UBC |
| Interaction | TBCD interactions | 6.18e-05 | 141 | 97 | 6 | int:TBCD | |
| Interaction | IL12RB1 interactions | 6.30e-05 | 87 | 97 | 5 | int:IL12RB1 | |
| Interaction | TRIM31 interactions | TUBB TUBB2B HNRNPUL1 PRPF8 TUBB2A TUBB4A TUBB4B SMPDL3B SEC16A CTNND1 | 6.67e-05 | 454 | 97 | 10 | int:TRIM31 |
| Interaction | TMPRSS5 interactions | 8.34e-05 | 48 | 97 | 4 | int:TMPRSS5 | |
| Interaction | GABRA1 interactions | 9.37e-05 | 152 | 97 | 6 | int:GABRA1 | |
| Interaction | WDR76 interactions | 9.65e-05 | 383 | 97 | 9 | int:WDR76 | |
| Interaction | KCTD13 interactions | NEDD4L KALRN RBP3 TUBB TUBB2B EDC4 TUBB2A TUBB4A TUBB4B NWD2 PPP2R5E NISCH VCAN SEC16A SCRIB CTNND1 ABHD12 PRRC2B | 1.05e-04 | 1394 | 97 | 18 | int:KCTD13 |
| Interaction | PEX14 interactions | 1.49e-04 | 237 | 97 | 7 | int:PEX14 | |
| Interaction | RPGR interactions | 1.64e-04 | 57 | 97 | 4 | int:RPGR | |
| Interaction | SNCA interactions | NEDD4L TUBB EDC4 PRPF8 TUBB2A FBXL5 VCAN SYNE2 SEC16A SCRIB CTNND1 ABHD12 | 1.66e-04 | 716 | 97 | 12 | int:SNCA |
| Interaction | NEAT1 interactions | 2.03e-04 | 24 | 97 | 3 | int:NEAT1 | |
| Interaction | ITLN1 interactions | 2.13e-04 | 61 | 97 | 4 | int:ITLN1 | |
| Interaction | ASB17 interactions | 2.30e-04 | 25 | 97 | 3 | int:ASB17 | |
| Interaction | METTL22 interactions | 2.59e-04 | 26 | 97 | 3 | int:METTL22 | |
| Interaction | TTC5 interactions | 2.73e-04 | 65 | 97 | 4 | int:TTC5 | |
| Interaction | B4GALT2 interactions | 2.76e-04 | 119 | 97 | 5 | int:B4GALT2 | |
| Interaction | EML3 interactions | 2.89e-04 | 66 | 97 | 4 | int:EML3 | |
| Interaction | EPHA4 interactions | 2.98e-04 | 188 | 97 | 6 | int:EPHA4 | |
| GeneFamily | Tubulins | 3.44e-08 | 26 | 66 | 5 | 778 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 2.05e-05 | 15 | 66 | 3 | 696 | |
| GeneFamily | Fibronectin type III domain containing | 2.95e-04 | 160 | 66 | 5 | 555 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 4.82e-04 | 42 | 66 | 3 | 602 | |
| GeneFamily | Fucosyltransferases|Blood group antigens | 9.97e-04 | 13 | 66 | 2 | 434 | |
| GeneFamily | F-box and leucine rich repeat proteins | 2.64e-03 | 21 | 66 | 2 | 558 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | NEDD4L VASN ZZEF1 SNED1 GANAB PLEKHM2 NISCH PKD1 ANKRD11 ABHD12 | 9.19e-06 | 457 | 99 | 10 | M1613 |
| Coexpression | GSE14308_TH17_VS_NATURAL_TREG_DN | 1.12e-05 | 200 | 99 | 7 | M3390 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP | 1.12e-05 | 200 | 99 | 7 | M4966 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | NEDD4L VASN ZZEF1 SNED1 GANAB PLEKHM2 NISCH PKD1 ANKRD11 ABHD12 | 1.17e-05 | 470 | 99 | 10 | MM1053 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | CRISPLD2 RNF17 TUBB4A SOWAHA GSDMD TDRD6 FUT4 RIC3 IL27RA L3MBTL4 | 4.07e-05 | 544 | 99 | 10 | M1936 |
| Coexpression | PEREZ_TP53_TARGETS | CRISPLD2 GAMT KALRN VASN EML6 OBSCN RNF213 ZNF284 SMPDL3B PTPRJ VCAN C1QTNF1 FUT4 ZNF649 PRRC2B | 4.38e-05 | 1201 | 99 | 15 | M4391 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | CRISPLD2 IL11RA RNF213 IL17RC SNED1 SMPDL3B SAT1 GSDMD ATG16L2 | 6.70e-06 | 290 | 96 | 9 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3 | 1.70e-05 | 411 | 96 | 10 | GSM605872_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.71e-05 | 179 | 96 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | CRISPLD2 IL11RA FAT3 EML6 RNF213 IL17RC C8orf34 SNED1 SMPDL3B SAT1 PTPRJ GSDMD CD44 C1QTNF1 ATG16L2 | 2.79e-05 | 967 | 96 | 15 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.55e-07 | 191 | 100 | 7 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-07 | 200 | 100 | 7 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-06 | 162 | 100 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D122|Adult / Lineage, Cell type, age group and donor | 2.37e-06 | 170 | 100 | 6 | a99cb3d21f8eb926886340ea99491e078e607648 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-06 | 174 | 100 | 6 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-06 | 174 | 100 | 6 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.09e-06 | 178 | 100 | 6 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | 18-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 3.85e-06 | 185 | 100 | 6 | d2a266724f3f70f746a78034f308d98f8b7a66e3 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 4.63e-06 | 191 | 100 | 6 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | Control-B_intermediate-0|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.69e-06 | 198 | 100 | 6 | 97e66b845053201247e2241739328cd73f33975c | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.86e-06 | 199 | 100 | 6 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 6.03e-06 | 200 | 100 | 6 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.03e-06 | 200 | 100 | 6 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | 85205dc68369d3e04df3460c1f3861ee2dc242a9 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-05 | 164 | 100 | 5 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | CTRL-Myeloid-Monocyte|CTRL / Disease state, Lineage and Cell class | 3.87e-05 | 168 | 100 | 5 | 13dca90c7b811e4d5e8fa44f5e892e29be9787a6 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 168 | 100 | 5 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.87e-05 | 168 | 100 | 5 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-05 | 169 | 100 | 5 | b059304543876f514d5c7214f1f0a2da00f10a67 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-05 | 169 | 100 | 5 | 945f737984c4de70a4e9c214053b005358053dd5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.09e-05 | 170 | 100 | 5 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | CTRL-Myeloid-Monocyte|Myeloid / Disease state, Lineage and Cell class | 4.21e-05 | 171 | 100 | 5 | bfa01571516a0b24476ae06cb07f56c5579dbd70 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 172 | 100 | 5 | 574ebdf36e45222bcd907cd2c2ee7ff50ed4573a | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 172 | 100 | 5 | 1627fa7035b0e0bbc82a1c0f000d8231254c680a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 173 | 100 | 5 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.70e-05 | 175 | 100 | 5 | cd42020fe57afeaadfbd3ef6d7375e66d71e9669 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 175 | 100 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-05 | 176 | 100 | 5 | 8e89471f838ea81235256cc2470f1c12c9b75f8a | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.82e-05 | 176 | 100 | 5 | a9e77681bcd36c382d53eb6f771349d55f98d744 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.96e-05 | 177 | 100 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 178 | 100 | 5 | ee674e379ee57e40eb2560ff5ed4c13d8db7ed9d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-05 | 178 | 100 | 5 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 178 | 100 | 5 | 6c45bf197d6c1be0ef7d3a644c0062acf1e24e4d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 178 | 100 | 5 | cd85dcefe94ee742db64b63e105e13532321894a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 180 | 100 | 5 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 180 | 100 | 5 | c0c07937839652e01df10cc1e70aa005800ea6f6 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 180 | 100 | 5 | 079c199425dd3c220f03c6dca1823946f07580a1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 181 | 100 | 5 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | PBMC-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 5.66e-05 | 182 | 100 | 5 | 4774066d0f9986abc3d13a2a3bc99ce4f1327ae0 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-05 | 182 | 100 | 5 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-05 | 182 | 100 | 5 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | FLU-Healthy-0|FLU / Virus stimulation, Condition and Cluster | 5.80e-05 | 183 | 100 | 5 | 058604ddb06b3bef131183d86b83b422dae8f6cb | |
| ToppCell | FLU-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 5.80e-05 | 183 | 100 | 5 | 7a6f18246c39864479e114f698581f667fa9c600 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 6.43e-05 | 187 | 100 | 5 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.59e-05 | 188 | 100 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.59e-05 | 188 | 100 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.59e-05 | 188 | 100 | 5 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 6.76e-05 | 189 | 100 | 5 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-05 | 189 | 100 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-05 | 189 | 100 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 7.11e-05 | 191 | 100 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 192 | 100 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | control-Myeloid-Neutrophils_3|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.46e-05 | 193 | 100 | 5 | 56daf3c59a124dd068af5409113913d9ee81a454 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.46e-05 | 193 | 100 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 7.46e-05 | 193 | 100 | 5 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 7.46e-05 | 193 | 100 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.46e-05 | 193 | 100 | 5 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.46e-05 | 193 | 100 | 5 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 194 | 100 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 194 | 100 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 7.65e-05 | 194 | 100 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 7.65e-05 | 194 | 100 | 5 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.83e-05 | 195 | 100 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | COVID-19-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 7.83e-05 | 195 | 100 | 5 | 9ad844d9d5aac39d133ae8ab9c4839300f08064c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.83e-05 | 195 | 100 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.83e-05 | 195 | 100 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | myeloid-CD14+_Monocyte|myeloid / Lineage and Cell class | 7.83e-05 | 195 | 100 | 5 | 60fab0c24c827567fb42bbd7eb165bf45178c198 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.83e-05 | 195 | 100 | 5 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | facs-Trachea-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.83e-05 | 195 | 100 | 5 | 0d1876f6fdc1eafeb60d6fd7da5bce737d2b4a5a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.03e-05 | 196 | 100 | 5 | d9b5eaca4089d5337f1175a663418c9c675cdd87 | |
| ToppCell | (0)_Myeloid-(000)_CD14+_Monocyte|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 8.03e-05 | 196 | 100 | 5 | e9718642ee2751c9d46a1b968547bdcb59cdfd30 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC|World / Primary Cells by Cluster | 8.22e-05 | 197 | 100 | 5 | 2c3b0072f8e1e09c77a85c6fc3133d1796932fb2 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.22e-05 | 197 | 100 | 5 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.22e-05 | 197 | 100 | 5 | 4a6eff66a17c5e89bda61d887b736f5c62b93bd7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC-29|World / Primary Cells by Cluster | 8.22e-05 | 197 | 100 | 5 | c5bc0e7eb85642b270efc2ba92b13a736af22052 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 8.42e-05 | 198 | 100 | 5 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.42e-05 | 198 | 100 | 5 | b73b9feb82997b654718aa27f33ca7b454214802 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 198 | 100 | 5 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 8.42e-05 | 198 | 100 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | facs-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-05 | 198 | 100 | 5 | e85ae846e293687fd193f4d565525d8d3bd1faea | |
| ToppCell | BAL-Severe|BAL / Compartment, Disease Groups and Clusters | 8.42e-05 | 198 | 100 | 5 | f63cfcc57f46094ea0673bbc70ea443ebaca6176 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 8.42e-05 | 198 | 100 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.42e-05 | 198 | 100 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 8.42e-05 | 198 | 100 | 5 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.62e-05 | 199 | 100 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 8.62e-05 | 199 | 100 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.62e-05 | 199 | 100 | 5 | 0dde17381b8a95bfddb4d1052b13d33f37b05d13 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.62e-05 | 199 | 100 | 5 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 8.62e-05 | 199 | 100 | 5 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.62e-05 | 199 | 100 | 5 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.62e-05 | 199 | 100 | 5 | a255484ba77bd2741a541da278efc8cf4abbe570 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.62e-05 | 199 | 100 | 5 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-Neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 8.83e-05 | 200 | 100 | 5 | b9538eb33ac86384e7e289a5a82fac4d56a7b9c2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 8.83e-05 | 200 | 100 | 5 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Interneuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 8.83e-05 | 200 | 100 | 5 | a313b9a8bde1ea80a6eae183b76fba46b86558b4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 200 | 100 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| Drug | Ph-F | RELN TUBB TUBB2B TUBB2A TUBB4A TUBB4B PPP2R5A PPP2R5D PPP2R5E | 1.34e-08 | 144 | 99 | 9 | CID000447564 |
| Drug | IKP104 | 4.44e-08 | 23 | 99 | 5 | CID000130739 | |
| Drug | 2,3,4-TCB | 4.44e-08 | 23 | 99 | 5 | CID000129239 | |
| Drug | 2,3,4-tabp | 4.44e-08 | 23 | 99 | 5 | CID000125548 | |
| Drug | N-acetylcolchinol | 4.44e-08 | 23 | 99 | 5 | CID000097865 | |
| Drug | NSC355636 | 4.44e-08 | 23 | 99 | 5 | CID000100176 | |
| Drug | parbendazole | 5.59e-08 | 24 | 99 | 5 | CID000026596 | |
| Drug | NSC-36768 | 5.59e-08 | 24 | 99 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 5.59e-08 | 24 | 99 | 5 | CID000014995 | |
| Drug | tropolone methyl ether | 5.59e-08 | 24 | 99 | 5 | CID000016546 | |
| Drug | colchicide | 5.59e-08 | 24 | 99 | 5 | CID000120712 | |
| Drug | AC1L4TG7 | 5.59e-08 | 24 | 99 | 5 | CID000163705 | |
| Drug | NBD-colcemid | 6.96e-08 | 25 | 99 | 5 | CID000130594 | |
| Drug | AC1Q6P06 | 6.96e-08 | 25 | 99 | 5 | CID000160263 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 6.96e-08 | 25 | 99 | 5 | CID000043264 | |
| Drug | allocolchicine | 6.96e-08 | 25 | 99 | 5 | CID000196989 | |
| Drug | 55623-37-5 | 6.96e-08 | 25 | 99 | 5 | CID006438440 | |
| Drug | MDL 27048 | 6.96e-08 | 25 | 99 | 5 | CID006439188 | |
| Drug | NSC527981 | 8.59e-08 | 26 | 99 | 5 | CID000352796 | |
| Drug | NSC332029 | 8.59e-08 | 26 | 99 | 5 | CID000100073 | |
| Drug | pironetin | 8.59e-08 | 26 | 99 | 5 | CID006438891 | |
| Drug | AC1L1J4H | 1.05e-07 | 27 | 99 | 5 | CID000004862 | |
| Drug | NSC292222 | 1.05e-07 | 27 | 99 | 5 | CID000099957 | |
| Drug | dinitroanilines | 1.05e-07 | 27 | 99 | 5 | CID000136400 | |
| Drug | NSC D-669356 | 1.05e-07 | 27 | 99 | 5 | CID000178028 | |
| Drug | NSC 370147 | 1.27e-07 | 28 | 99 | 5 | CID000182762 | |
| Drug | NSC72302 | 1.27e-07 | 28 | 99 | 5 | CID000118078 | |
| Drug | oxibendazole | 1.53e-07 | 29 | 99 | 5 | CID000004622 | |
| Drug | AC1NBBHE | 1.83e-07 | 30 | 99 | 5 | CID004490620 | |
| Drug | eleutherobin | 1.83e-07 | 30 | 99 | 5 | CID006918335 | |
| Drug | azatoxin | 1.83e-07 | 30 | 99 | 5 | CID000125383 | |
| Drug | NSC617668 | 1.83e-07 | 30 | 99 | 5 | CID000357989 | |
| Drug | citostal | 1.83e-07 | 30 | 99 | 5 | CID000018991 | |
| Drug | thiocolchicine | 1.83e-07 | 30 | 99 | 5 | CID000017648 | |
| Drug | tropone | 2.18e-07 | 31 | 99 | 5 | CID000010881 | |
| Drug | NSC609395 | 2.18e-07 | 31 | 99 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 2.18e-07 | 31 | 99 | 5 | CID000100524 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 2.18e-07 | 31 | 99 | 5 | CID000032851 | |
| Drug | AC1L3V8I | 2.18e-07 | 31 | 99 | 5 | CID000122777 | |
| Drug | NSC332598 | 2.18e-07 | 31 | 99 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 2.18e-07 | 31 | 99 | 5 | CID000023678 | |
| Drug | AC1L1G95 | 2.58e-07 | 32 | 99 | 5 | CID000003583 | |
| Drug | NSC153858 | 2.58e-07 | 32 | 99 | 5 | CID000547450 | |
| Drug | 2-demethylcolchicine | 2.58e-07 | 32 | 99 | 5 | CID000023757 | |
| Drug | CA4P | 3.02e-07 | 33 | 99 | 5 | CID000370232 | |
| Drug | taltobulin | 3.02e-07 | 33 | 99 | 5 | CID006918637 | |
| Drug | mebendazole | 3.02e-07 | 33 | 99 | 5 | CID000004030 | |
| Drug | NSC376450 | 3.53e-07 | 34 | 99 | 5 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 3.53e-07 | 34 | 99 | 5 | CID000161091 | |
| Drug | discodermolide | 4.11e-07 | 35 | 99 | 5 | CID000643668 | |
| Drug | AC1O5Y0F | 5.48e-07 | 37 | 99 | 5 | CID006442852 | |
| Drug | DTAF | 5.48e-07 | 37 | 99 | 5 | CID000123934 | |
| Drug | albendazole | 5.48e-07 | 37 | 99 | 5 | CID000002082 | |
| Drug | baccatin III | 5.48e-07 | 37 | 99 | 5 | CID000065366 | |
| Drug | laulimalide | 6.29e-07 | 38 | 99 | 5 | CID006918457 | |
| Drug | gnoscopine | 6.29e-07 | 38 | 99 | 5 | CID000004544 | |
| Drug | colchiceine | 6.29e-07 | 38 | 99 | 5 | CID000010156 | |
| Drug | erianin | 7.19e-07 | 39 | 99 | 5 | CID000356759 | |
| Drug | Dolastatin 10 | 7.19e-07 | 39 | 99 | 5 | CID000100208 | |
| Drug | AC1L8GZ1 | 8.19e-07 | 40 | 99 | 5 | CID000381235 | |
| Drug | lumicolchicine | 9.29e-07 | 41 | 99 | 5 | CID000072624 | |
| Drug | nocodazole | POLD1 TUBB TUBB2B TUBB2A ZNF2 TUBB4A TUBB4B PPP2R5A PPP2R5D PPP2R5E ANAPC1 CTNND1 | 1.11e-06 | 477 | 99 | 12 | CID000004122 |
| Drug | AC1L9CY0 | 1.19e-06 | 43 | 99 | 5 | CID000396644 | |
| Drug | Stylophorin | 1.19e-06 | 43 | 99 | 5 | CID000010147 | |
| Drug | methyl ether | 1.49e-06 | 45 | 99 | 5 | CID000008254 | |
| Drug | bromocolchicine | 1.90e-06 | 21 | 99 | 4 | CID000161518 | |
| Drug | Ustiloxin A | 1.90e-06 | 21 | 99 | 4 | CID000164454 | |
| Drug | SRI-3072 | 1.90e-06 | 21 | 99 | 4 | CID000493469 | |
| Drug | colchifoline | 1.90e-06 | 21 | 99 | 4 | CID000100132 | |
| Drug | NSC654663 | 2.30e-06 | 49 | 99 | 5 | CID000375252 | |
| Drug | 3,4,5-trimethoxyacetophenone | 2.32e-06 | 22 | 99 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 2.32e-06 | 22 | 99 | 4 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 2.32e-06 | 22 | 99 | 4 | CID000098538 | |
| Drug | SureCN13401588 | 2.32e-06 | 22 | 99 | 4 | CID009897422 | |
| Drug | N-methyldemecolcine | 2.32e-06 | 22 | 99 | 4 | CID000023759 | |
| Drug | NSC-339672 | 2.32e-06 | 22 | 99 | 4 | CID000433930 | |
| Drug | Z)-combretastatin A-4 | 2.55e-06 | 50 | 99 | 5 | CID000072686 | |
| Drug | GaCl3 | 2.55e-06 | 50 | 99 | 5 | CID000026010 | |
| Drug | fluorescein-colchicine | 2.79e-06 | 23 | 99 | 4 | CID003035871 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 2.79e-06 | 23 | 99 | 4 | CID000006858 | |
| Drug | 3-demethylthiocolchicine | 2.79e-06 | 23 | 99 | 4 | CID000084076 | |
| Drug | AC1L2P05 | 2.79e-06 | 23 | 99 | 4 | CID000125688 | |
| Drug | NSC-373301 | 2.79e-06 | 23 | 99 | 4 | CID000341375 | |
| Drug | combretastatin | 2.81e-06 | 51 | 99 | 5 | CID000100154 | |
| Drug | magnesium sulfate | 3.10e-06 | 52 | 99 | 5 | CID000024083 | |
| Drug | vinflunine | 3.10e-06 | 52 | 99 | 5 | CID000157688 | |
| Drug | moscatilin | 3.34e-06 | 24 | 99 | 4 | CID000176096 | |
| Drug | 7-epi-cephalomannine | 3.34e-06 | 24 | 99 | 4 | CID000330401 | |
| Drug | NABV | 3.34e-06 | 24 | 99 | 4 | CID000175959 | |
| Drug | tropolone | 3.41e-06 | 53 | 99 | 5 | CID000010789 | |
| Drug | NSC 89199 | 3.75e-06 | 54 | 99 | 5 | CID000003268 | |
| Drug | S)-monastrol | 3.75e-06 | 54 | 99 | 5 | CID000794323 | |
| Drug | mpMap | 3.97e-06 | 25 | 99 | 4 | CID000100806 | |
| Drug | 1069C85 | 3.97e-06 | 25 | 99 | 4 | CID006918099 | |
| Drug | CA1P | 3.97e-06 | 25 | 99 | 4 | CID006918545 | |
| Drug | peloruside A | 3.97e-06 | 25 | 99 | 4 | CID006918506 | |
| Drug | NSC142227 | 3.97e-06 | 25 | 99 | 4 | CID000073427 | |
| Drug | 2,4,3',5'-tetramethoxystilbene | 3.97e-06 | 25 | 99 | 4 | ctd:C440850 | |
| Drug | AC1L8WWP | 4.50e-06 | 56 | 99 | 5 | CID000388944 | |
| Drug | 2,5-hexanedione | 4.50e-06 | 56 | 99 | 5 | CID000008035 | |
| Disease | facial paralysis (implicated_via_orthology) | 8.16e-11 | 10 | 96 | 5 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 8.16e-11 | 10 | 96 | 5 | DOID:0090132 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 8.16e-11 | 10 | 96 | 5 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 8.16e-11 | 10 | 96 | 5 | DOID:0112227 (implicated_via_orthology) | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 2.55e-10 | 12 | 96 | 5 | DOID:0050997 (implicated_via_orthology) | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 1.85e-06 | 8 | 96 | 3 | DOID:14452 (implicated_via_orthology) | |
| Disease | Autosomal dominant polycystic kidney disease | 3.14e-05 | 3 | 96 | 2 | cv:C0085413 | |
| Disease | aspartate aminotransferase measurement | MAGI1 NEDD4L KALRN OBSCN AKNA RNF213 C8orf34 CCDC197 NAA25 HMCN2 PTPRJ ATG16L2 | 3.75e-05 | 904 | 96 | 12 | EFO_0004736 |
| Disease | Colorectal Carcinoma | 9.77e-05 | 702 | 96 | 10 | C0009402 | |
| Disease | Polycystic kidney disease, type 2 | 2.18e-04 | 7 | 96 | 2 | C2751306 | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 2.90e-04 | 8 | 96 | 2 | C0887850 | |
| Disease | Polycystic Kidney, Autosomal Dominant | 3.72e-04 | 9 | 96 | 2 | C0085413 | |
| Disease | left ventricular systolic function measurement | 4.01e-04 | 44 | 96 | 3 | EFO_0008206 | |
| Disease | household income | 4.85e-04 | 304 | 96 | 6 | EFO_0009695 | |
| Disease | intracranial aneurysm (is_implicated_in) | 6.77e-04 | 12 | 96 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | survival time, lung adenocarcinoma | 6.77e-04 | 12 | 96 | 2 | EFO_0000571, EFO_0000714 | |
| Disease | hepcidin:transferrin saturation ratio | 1.07e-03 | 15 | 96 | 2 | EFO_0007902 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 1.07e-03 | 15 | 96 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Polyposis, Adenomatous Intestinal | 1.22e-03 | 16 | 96 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.22e-03 | 16 | 96 | 2 | C2713443 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.37e-03 | 67 | 96 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | Adenomatous Polyposis Coli | 1.38e-03 | 17 | 96 | 2 | C0032580 | |
| Disease | diet measurement, HOMA-B | 1.73e-03 | 19 | 96 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | cancer (implicated_via_orthology) | 1.86e-03 | 268 | 96 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Cleft Palate | 2.37e-03 | 81 | 96 | 3 | C0008925 | |
| Disease | female reproductive system disease | 2.53e-03 | 23 | 96 | 2 | EFO_0009549 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 3.24e-03 | 26 | 96 | 2 | C0009405 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DPEEDEPTLEASWPH | 136 | Q16537 | |
| PTTHQGPWEESELDS | 66 | Q8NAA4 | |
| AVITEEPVEWAHPSE | 1941 | Q6UB99 | |
| TDWGVLVPSVPSEDE | 981 | P13611 | |
| GLELGEDTPHVCWEP | 446 | P57764 | |
| HQPWILPSDTESEGV | 496 | Q49A92 | |
| PEEDEPTLEAAWPHL | 196 | Q14738 | |
| PEGCTGWEEPEEVLV | 61 | Q8NCU1 | |
| REHIPSVEPQVGEEW | 916 | Q8IXJ9 | |
| SWIDPPEEEHSPQLT | 716 | Q9HCE9 | |
| WLHEDTGPESDPVVI | 436 | Q9ULI1 | |
| SPVEPWEGISDHSGI | 11 | Q9H714 | |
| SRLTEHQVAEPPEDW | 936 | Q6P2E9 | |
| QPEEDVTIGVWHTVP | 131 | Q8N2K0 | |
| EPIVPELCIDHLWTE | 401 | Q9H1A4 | |
| TPGDVPWLSHPSVEE | 9126 | Q8WXI7 | |
| QPETIDSWVAHPGTE | 11231 | Q8WXI7 | |
| PAWSTVEPAGLEEVI | 266 | Q14626 | |
| TSWPDHGVPDTTDLL | 1201 | Q12913 | |
| EDPWAGLEPVSVVDI | 146 | Q8TAP9 | |
| EHGLATPEGLTVDWI | 1331 | Q9NZR2 | |
| QTEEWTEDHSALVPP | 421 | Q96QZ7 | |
| LWVPPGGHVELEEEL | 121 | P0C025 | |
| GLPEWCPHSEEATLE | 691 | Q96H55 | |
| PPWGIQAHTAEEVDL | 251 | P22083 | |
| VELRVLEPPHWGADE | 1241 | Q8NDA2 | |
| DFILWTGDDTPHVPD | 86 | Q92485 | |
| VPHIDTQAGWPEVLE | 81 | Q32MK0 | |
| EVETAPIPEENHVWL | 251 | Q9H0B8 | |
| WGEDEPDEESHTPLP | 1826 | O60229 | |
| EDDPLEATVHWAPPT | 141 | Q6UWB1 | |
| EWTLHPAPEGTADSE | 1041 | Q8IWU2 | |
| VEADSPDIHPIGWCD | 341 | Q8NA19 | |
| EESDHLGWESLPTDP | 271 | Q7Z5B4 | |
| GKDWHLVTEECVPPT | 1691 | P78509 | |
| VWSAVTPSPEHLGDE | 361 | O00750 | |
| PEVAAHTWLLDDEPV | 4366 | Q5VST9 | |
| HPIQAEASTEEEPLW | 341 | O95704 | |
| SDIDVWVPEPDHSEV | 1656 | Q3L8U1 | |
| AGLWTPEAVIEHPDA | 41 | Q9H2M3 | |
| EWEGTEELPSPPDHA | 36 | Q9BXJ1 | |
| WQPLDTVHSEIPDET | 136 | Q5T4I8 | |
| VVCPPTLTGHWVDEV | 1331 | O14981 | |
| VHPIPDEDSPWITDS | 201 | P16070 | |
| WEAEDTHLSCPEPTV | 411 | Q6P4F1 | |
| PWPHVEGVEVDLESI | 71 | Q86SF2 | |
| WSSLDEEELHPENSP | 166 | Q96AQ9 | |
| VGTVIAWLETHDPDL | 951 | Q8TDW7 | |
| EDVDSPASSHEPLAW | 96 | Q7Z591 | |
| LWEDVAPTLPDGHFD | 116 | Q14353 | |
| PTCEGIWPAHSDITD | 1181 | Q6ZMW3 | |
| GEEIDNEHPWTKPVS | 456 | Q9UKA1 | |
| IDGAVIPDHWLDPSA | 826 | P18858 | |
| WCSVPVEPGDIIHLE | 86 | P51530 | |
| VVHDSPVPEVTWGPE | 606 | Q12770 | |
| LEADVLWSDVVSHPP | 286 | P28340 | |
| VIIPHSGWEREPNED | 501 | O60716 | |
| THCSPVSLEPWGDEE | 31 | Q8NAC3 | |
| VVALPWLSEGEHVVD | 896 | P98161 | |
| EPDPHVVRIGWSLDS | 276 | Q9BUJ2 | |
| GLVHWEDPTDESLGP | 746 | Q8IWE5 | |
| PEHIKEPIWETLSEE | 181 | P82664 | |
| SDIPDHIPEEVVVWF | 1101 | O60522 | |
| SVDSIPLEWDHTGDV | 6411 | Q8WXH0 | |
| EWSISEDSGPTHDDP | 151 | P12259 | |
| GIHIPDRDAAWELEP | 221 | Q9BWX1 | |
| PCHEWLSDEDLVPVL | 96 | Q9H469 | |
| SADPEGHFETPIWIE | 876 | Q14697 | |
| WEVISDEHGIDPTGS | 21 | Q13885 | |
| VAEVPKEHWTPEGHS | 56 | P21673 | |
| ELPGQTLHWGPEATE | 1241 | Q14160 | |
| HVVWDAPTPGSLLEA | 1121 | Q8TER0 | |
| SLEEAEPIPDIHWGI | 451 | P13798 | |
| EEDEPTLEASWPHIQ | 146 | Q15172 | |
| VWDPSPEEIISNEVH | 881 | Q9BXT8 | |
| ITEPHHIWPTLTDEE | 1961 | Q6P2Q9 | |
| ASEAPEEEVSLPWVH | 3801 | Q63HN8 | |
| WECTELIHDIPLPEH | 366 | Q96HI0 | |
| PESVSLDWETKPEIH | 86 | Q9BSG1 | |
| WEGVGVTPHVVVPAE | 1206 | P10745 | |
| PEEESLAAPTWLVHL | 1866 | O15027 | |
| PLEPSEHEWLVRTAG | 306 | Q2M3V2 | |
| WEVISDEHGIDPTGT | 21 | P04350 | |
| PPLEETDWSHSQLLD | 1466 | A6NE52 | |
| WEVISDEHGIDPTGS | 21 | Q9BVA1 | |
| WEVISDEHGIDPTGT | 21 | P68371 | |
| DEWEPEGTTLEGPVT | 266 | Q9Y2I1 | |
| WEVISDEHGIDPTGT | 21 | P07437 | |
| EILSITHDPGEEWVL | 331 | A0A1W2PR48 | |
| ESLGLWGPEEEPHLL | 1321 | Q5JSZ5 | |
| LISIPHVWCHPEEEE | 6 | Q3KNS6 | |
| PWVRESHVTLASPEE | 311 | Q6EMK4 | |
| IEMETVPEAGPHEEW | 106 | Q9UK13 | |
| LLAEWPSHVPVSEDI | 2626 | O43149 | |
| EWLIEHAEDPTIDTP | 226 | Q9BSL1 | |
| EPWDHTEKTEEEPVS | 181 | Q96RL1 | |
| EDAGLDPHFVPTELW | 111 | Q8NA77 | |
| LESVPETGPHEEWSC | 86 | Q2VY69 | |
| LWTLEDEIHSPAHPE | 66 | Q9BS31 | |
| LIEEAWSPPAEGEHS | 276 | Q14CX7 | |
| WSPPAEGEHSLEGEV | 281 | Q14CX7 | |
| GGDVPEPWETISEEV | 266 | Q96PU5 |